Skip to main content

XiFin

Category: AI in Healthcare

XiFin provides AI-powered SaaS solutions for revenue cycle management, workflow automation, and healthcare informatics targeting diagnostic and healthcare providers. XiFin was founded in 1997. The company is led by Lâle White. Based in San Diego, United States. Team size: 501-1000. Total funding raised: $28 million over 4 rounds with additional undisclosed growth funding.. Latest round: Growth Funding. Key investors include ["GTCR","Warburg Pincus","Avista Healthcare Partners","The Goldman Sachs Group","Boulder Ventures","Merck Global Health Innovation Fund"].

Founded
1997
Headquarters
San Diego, United States
Team size
501-1000
Total funding
$28 million over 4 rounds with additional undisclosed growth funding.

Value proposition

Optimizes healthcare economics by improving cash collections, automating billing, and delivering actionable business intelligence to enhance financial performance.

Products and solutions

["XiFin RPM (Revenue Performance Management)","XiFin LIS (Laboratory Information System)","XiFin Pharmacy Solutions","XiFin Patient Engagement & Access","VisualStrata (Precision Medicine Informatics)","XiFin Empower AI (AI RCM Ecosystem)"]

Unique value

Combines cloud-based AI with deep domain expertise in diagnostics and pharmacy sectors, connecting diverse healthcare stakeholders for streamlined financial and operational workflows.

Target customer

Diagnostic labs, pathology practices, specialty pharmacies, medical device companies, and hospital outreach laboratories.

Industries served

["Healthcare","Diagnostics (Laboratories, Pathology)","Pharmacy","Medical Devices"]

Technology advantage

AI-driven automation engine manages complex billing codes and payor rules, reducing errors and improving claim accuracy while providing robust business intelligence for revenue optimization.

How they differentiate

Specializes in AI-driven revenue cycle management tailored for diagnostics and laboratories, automating reimbursement and billing with advanced analytics specific to this niche.

Main competitors

["Change Healthcare","Athenahealth","Quadax"]

Key partnerships

["American Clinical Laboratory Association (ACLA)","California Clinical Laboratory Association (CCLA)","Careviso","Sonic Healthcare","Caris Life Sciences","Science and Medicine Group","AuntMinnie","Future of Pharmacy Care Coalition"]

Notable customers

["LabCorp","Quest Diagnostics","Pathology Associates Medical Laboratories (PAML)","MercyOne Des Moines Laboratory"]

Major milestones

["Secured new growth funding and added Jeff Margolis to the Board of Directors.","Surpassed $40 billion in processed annual laboratory claims.","Acquired by GTCR in 2014.","Earned HITRUST R2 certification for information security.","Launched XiFin Empower AI RCM Ecosystem (March 2026).","Launched Empower AI for Specialty Pharmacy at Asembia AXS26 (April 2026).","Introduced Empower AI Appeals Agent (April 2026).","OmniSYS subsidiary acquired Rx-Net (December 2025).","OmniSYS subsidiary acquired STRAND Clinical Technologies (January 2026)."]

Growth metrics

Processes over $40 billion in annual gross claims; customers have achieved 20-40% improvements in cash collections.

Market positioning

Leading provider of cloud-based RCM and workflow automation for healthcare diagnostics, known for enhancing cash collections and reducing denials.

Geographic focus

Primarily serves customers in the United States, headquartered in San Diego, California.

Patents and IP

No publicly available patent information; innovations are embedded in proprietary AI algorithms and workflow automation technology.

About Lâle White

Lâle White is the founder of XiFin and has served as Executive Chair and CEO since 1997. Before founding XiFin, she held various leadership roles at Laboratory Corporation of America (LabCorp), focusing on business development and regulatory affairs.

Official website: